ATE369138T1 - Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden - Google Patents

Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden

Info

Publication number
ATE369138T1
ATE369138T1 AT04755494T AT04755494T ATE369138T1 AT E369138 T1 ATE369138 T1 AT E369138T1 AT 04755494 T AT04755494 T AT 04755494T AT 04755494 T AT04755494 T AT 04755494T AT E369138 T1 ATE369138 T1 AT E369138T1
Authority
AT
Austria
Prior art keywords
alkyl
duration
activity
inflammatory steroids
action
Prior art date
Application number
AT04755494T
Other languages
English (en)
Inventor
Nicholas S Bodor
Original Assignee
Nicholas S Bodor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas S Bodor filed Critical Nicholas S Bodor
Application granted granted Critical
Publication of ATE369138T1 publication Critical patent/ATE369138T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04755494T 2003-06-19 2004-06-17 Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden ATE369138T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47949703P 2003-06-19 2003-06-19

Publications (1)

Publication Number Publication Date
ATE369138T1 true ATE369138T1 (de) 2007-08-15

Family

ID=33539182

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04755494T ATE369138T1 (de) 2003-06-19 2004-06-17 Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden

Country Status (7)

Country Link
US (2) US7419971B2 (de)
EP (1) EP1658083B1 (de)
AT (1) ATE369138T1 (de)
CA (1) CA2558941C (de)
DE (1) DE602004008083T2 (de)
HK (1) HK1089691A1 (de)
WO (1) WO2004112800A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799331B2 (en) 2005-08-04 2010-09-21 Taro Pharmaceutical North America, Inc. Oral suspension of prednisolone acetate
US7687484B2 (en) 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
TW200902032A (en) * 2007-03-26 2009-01-16 Combinatorx Inc Split dose corticosteroid therapy
CA3016981C (en) * 2015-03-12 2023-06-27 Cristcot Llc Hydrocortisone acetate suppository formulation for treatment of disease
WO2019155468A1 (en) 2018-02-08 2019-08-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Heteroaryl compounds, pharmaceutical compositions thereof, and their therapeutic use
SG11202113211PA (en) 2019-06-03 2021-12-30 Biotheryx Inc Non-hygroscopic crystalline salts of a pyrazole compound, and pharmaceutical compositions and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384372A (en) 1971-01-20 1975-02-19 Glaxo Lab Ltd Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
CH628355A5 (de) 1976-02-24 1982-02-26 Ciba Geigy Ag Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
EP0502080A4 (en) * 1989-11-21 1993-02-10 The University Of Melbourne Anti-inflammatory compositions and methods
US5981517A (en) * 1996-05-09 1999-11-09 Soft Drugs, Inc. Androstene derivatives
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
HK1089691A1 (en) 2006-12-08
DE602004008083D1 (de) 2007-09-20
CA2558941C (en) 2012-05-15
EP1658083A1 (de) 2006-05-24
CA2558941A1 (en) 2004-12-29
WO2004112800A1 (en) 2004-12-29
US20050020551A1 (en) 2005-01-27
US20080261930A1 (en) 2008-10-23
US7776846B2 (en) 2010-08-17
US7419971B2 (en) 2008-09-02
EP1658083B1 (de) 2007-08-08
DE602004008083T2 (de) 2008-04-24

Similar Documents

Publication Publication Date Title
HK1089690A1 (en) Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
HK1089691A1 (en) Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
CO5700776A2 (es) Compuestos utiles para el tratamiento de enfermedades
TW200603813A (en) Cyclic progestin regimens and kits
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
DK1779858T3 (da) Anvendelse af selenforbindelser, især selengær, til forandring af kognitiv funktion
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
BRPI0506125A (pt) anticorpo antiglipicano 3
DE60326453D1 (de) Die verwendung von hmgb1 zur behandlung von gewebeverletzungen und/oder zur unterstützung der gewebewiederherstellung
HK1112941A1 (en) Use of a33 antigens and jam-it a33
DE602004028651D1 (de) Neutralisierbares epitop von hgf und an dieses bindende neutralisierender antikörper
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
ATE411353T1 (de) Silikonzusammensetzung, die durch hydrosilylierung in gegenwart eines carben-metall-katalysators vernetzt werden kann und katalysator
ES2133582T3 (es) Esteroides heterociclicos de c17 delta16-insaturados utiles como inhibidores de esteroide c17-20 liasa.
DE602004026558D1 (de) Selektive nichtsteroidale glucocorticoid-rezeptor- modulatoren
TW200720842A (en) A squarilium compound and the short-wave length source photo polymerization composition using thereof
ATE492282T1 (de) Zusammensetzung aus steroiden mit transporterweiterter corticosteroid-aktivität
HK1088028A1 (en) Use of metal alkanedithiols as crosslkinking agents for unsaturated rubbers
DK1758970T3 (da) Røbeblanding til lugtfrit gasformigt brændstof
TW200714602A (en) 5,6-dialkyl-7-aminoazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds
CO6150165A2 (es) Nevos derivados 5,7-disustituidos de [1,3]tiazolo[4,5-d]pirimidin-2 (3h)-ona y su uso en terapia
WO2003104254A3 (en) NOVEL ANDROSTANE AND ANDROSTENE DERIVATIVES WITH ASCORBIC ACID AND THEIR USE IN THE TREATMENT OR PREVENTION OF DIFFERENT CONDITIONS, DISEASES AND DISORDERS
DK1635843T3 (da) Terapi, der omfatter dienogest for hormonerstatning og depression

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties